Best Leukemia chemotherapy doctors in Barcelona: TOP 4 doctors

• Dr. Jaume Mora Graupera specializes in pediatric leukemia chemotherapy.
• Utilizes precision medicine approaches, targeted therapies, and hematopoietic stem cell transplantation.
• Trained in pediatric hematology oncology at Weill Cornell and Memorial Sloan Kettering, USA.
• Expert in innovative leukemia treatments: CAR T-cell therapy, tyrosine kinase inhibitors, and immunotherapy.
• Professional memberships include the International Society of Pediatric Oncology and the American Society of Clinical Oncology.
• Offers remote consultations for international patients undergoing leukemia chemotherapy.
• Languages spoken: English and Spanish, facilitating diverse patient communication.

• Dr. Susana Rives Sola specializes in pediatric leukemia chemotherapy.
• Utilizes cutting-edge treatments: CAR-T therapy, precision medicine, and targeted therapy.
• Trained internationally, including in the United States and European countries.
• Holds significant certifications in pediatric hematology and oncology.
• Member of renowned professional bodies like the European Hematology Association.
• Offers online consultations for global patients seeking leukemia chemotherapy expertise.
• Fluent in multiple languages, enhancing communication with diverse patients.

• Dr. Francesc Bosch specializes in innovative Leukemia chemotherapy techniques.
• Employs methods like targeted therapy, immunotherapy, and combination chemotherapy.
• International training includes a fellowship at Columbia University, New York.
• Renowned for leading over 80 clinical trials, advancing Leukemia treatments.
• Professor of Haematology, focusing on Chronic Lymphocytic Leukemia research.
• Member of the Spanish group for CLL study, enhancing treatment protocols.
• Fluent in English and Spanish, facilitating comprehensive patient consultations.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia